Skip to main content
Clinical Trials/NL-OMON31941
NL-OMON31941
Not yet recruiting
Phase 2

GAL Evaluation Along with B-type Natriuretic Peptide in Acutely Decompensated HF - GALLANT

BIOSITE Incorporate0 sites25 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
BIOSITE Incorporate
Enrollment
25
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
BIOSITE Incorporate

Eligibility Criteria

Inclusion Criteria

  • (Males or females 18 years of age or older)
  • Patients with symptoms of new or decompensated heart failure and who will be treated with at least one dose of IV diuretic
  • Ability to draw blood samples

Exclusion Criteria

  • Acute myocardial infarction or active ischemia
  • Cardiogenic shock or other clinical conditions contraindicate administration of IV diuretic
  • History of marked renal insufficiency (serum creatinine \>3\.0 mg/dL), on dialysis or in imminent need of dialysis at enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials